OBJECTIVE: Neonatal white matter injury (NWMI) is the leading cause of cerebral palsy and other neurocognitive deficits in prematurely-born children, and no restorative therapies exist. Our objective was to determine the fate and effect of glial restricted precursor cell (GRP) transplantation in an ischemic mouse model of NWMI. METHODS: Neonatal CD-1 mice underwent unilateral carotid artery ligation on postnatal-Day 5 (P5). At P22, intracallosal injections of either enhanced green fluorescent protein (eGFP) + GRPs or saline were performed in control and ligated mice. Neurobehavioral and postmortem studies were performed at 4 and 8 weeks post-transplantation. RESULTS: GRP survival was comparable at 1 month but significantly lower at 2 months post-transplantation in NWMI mice compared with unligated controls. Surviving cells showed better migration capability in controls; however, the differentiation capacity of transplanted cells was similar in control and NWMI. Saline-treated NWMI mice showed significantly altered response in startle amplitude and prepulse inhibition (PPI) paradigms compared with unligated controls, while these behavioral tests were completely normal in GRP-transplanted animals. Similarly, there was significant increase in hemispheric myelin basic protein density, along with significant decrease in pathologic axonal staining in cell-treated NWMI mice compared with saline-treated NWMI animals. INTERPRETATION: The reduced long-term survival and migration of transplanted GRPs in an ischemia-induced NWMI model suggests that neonatal ischemia leads to long-lasting detrimental effects on oligodendroglia even months after the initial insult. Despite limited GRP-survival, behavioral, and neuropathological outcomes were improved after GRP-transplantation. Our results suggest that exogenous GRPs improve myelination through trophic effects in addition to differentiation into mature oligodendrocytes.
OBJECTIVE:Neonatal white matter injury (NWMI) is the leading cause of cerebral palsy and other neurocognitive deficits in prematurely-born children, and no restorative therapies exist. Our objective was to determine the fate and effect of glial restricted precursor cell (GRP) transplantation in an ischemicmouse model of NWMI. METHODS: Neonatal CD-1mice underwent unilateral carotid artery ligation on postnatal-Day 5 (P5). At P22, intracallosal injections of either enhanced green fluorescent protein (eGFP) + GRPs or saline were performed in control and ligated mice. Neurobehavioral and postmortem studies were performed at 4 and 8 weeks post-transplantation. RESULTS: GRP survival was comparable at 1 month but significantly lower at 2 months post-transplantation in NWMI mice compared with unligated controls. Surviving cells showed better migration capability in controls; however, the differentiation capacity of transplanted cells was similar in control and NWMI. Saline-treated NWMI mice showed significantly altered response in startle amplitude and prepulse inhibition (PPI) paradigms compared with unligated controls, while these behavioral tests were completely normal in GRP-transplanted animals. Similarly, there was significant increase in hemispheric myelin basic protein density, along with significant decrease in pathologic axonal staining in cell-treated NWMI mice compared with saline-treated NWMI animals. INTERPRETATION: The reduced long-term survival and migration of transplanted GRPs in an ischemia-induced NWMI model suggests that neonatal ischemia leads to long-lasting detrimental effects on oligodendroglia even months after the initial insult. Despite limited GRP-survival, behavioral, and neuropathological outcomes were improved after GRP-transplantation. Our results suggest that exogenous GRPs improve myelination through trophic effects in addition to differentiation into mature oligodendrocytes.
Authors: J Herrera; H Yang; S C Zhang; C Proschel; P Tresco; I D Duncan; M Luskin; M Mayer-Proschel Journal: Exp Neurol Date: 2001-09 Impact factor: 5.330
Authors: Mark Noble; Margot Mayer-Pröschel; Jeannette E Davies; Stephen J A Davies; Christoph Pröschel Journal: Curr Opin Neurol Date: 2011-12 Impact factor: 5.710
Authors: D Chabas; S E Baranzini; D Mitchell; C C Bernard; S R Rittling; D T Denhardt; R A Sobel; C Lock; M Karpuj; R Pedotti; R Heller; J R Oksenberg; L Steinman Journal: Science Date: 2001-11-23 Impact factor: 47.728
Authors: Yutaka Itokazu; Nobuyoshi Tajima; Laura Kerosuo; Pentti Somerharju; Hannu Sariola; Robert K Yu; Reijo Käkelä Journal: Neurochem Res Date: 2016-02-25 Impact factor: 3.996
Authors: Elizabeth Nance; Michael Porambo; Fan Zhang; Manoj K Mishra; Markus Buelow; Rachel Getzenberg; Michael Johnston; Rangaramanujam M Kannan; Ali Fatemi; Sujatha Kannan Journal: J Control Release Date: 2015-07-13 Impact factor: 9.776
Authors: Rohit K Srivastava; Anna Jablonska; Chengyan Chu; Lydia Gregg; Jeff W M Bulte; Raymond C Koehler; Piotr Walczak; Miroslaw Janowski Journal: Stem Cells Dev Date: 2019-03-28 Impact factor: 3.272
Authors: Christina L Nemeth; Sophia N Tomlinson; Rishi Sharma; Anjali Sharma; Sujatha Kannan; Rangaramanujam M Kannan; Ali Fatemi Journal: Nanoscale Date: 2020-07-29 Impact factor: 7.790
Authors: Romy Sweda; Andre W Phillips; Joel Marx; Michael V Johnston; Mary Ann Wilson; Ali Fatemi Journal: Stem Cells Dev Date: 2016-06-16 Impact factor: 3.272
Authors: Shreyas Kuddannaya; Wei Zhu; Chengyan Chu; Anirudha Singh; Piotr Walczak; Jeff W M Bulte Journal: ACS Appl Mater Interfaces Date: 2021-05-12 Impact factor: 10.383
Authors: Ha Neui Kim; Malk Eun Pak; Myung Jun Shin; Soo Yeon Kim; Yong Beom Shin; Young Ju Yun; Hwa Kyoung Shin; Byung Tae Choi Journal: Int J Mol Med Date: 2017-04-27 Impact factor: 4.101
Authors: Ghulam Muhammad; Jiadi Xu; Jeff W M Bulte; Anna Jablonska; Piotr Walczak; Miroslaw Janowski Journal: Sci Rep Date: 2017-07-05 Impact factor: 4.379